FDA
approval
· 2022-01-25
FDA Approved: CARBIDOPA, LEVODOPA AND ENTACAPONE — Original Application (Rising Pharma Holdings, Inc.)
Summary
FDA approved Rising Pharma's original application for a generic fixed-dose combination of carbidopa, levodopa, and entacapone. This approval makes the Parkinson…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA, LEVODOPA AND ENTACAPONE)